Evidence map›Paper›PMID 38238559›Full record

ArticleNature methods2024

Deep generative design of RNA family sequences.

Shunsuke Sumi, Michiaki Hamada, Hirohide Saito

Abstract read
PubMed Publisher
In one paragraph

Article in Nature methods, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
12.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. De novo design of RNA pseudoknots with deep learning.bioRxiv : the preprint server for biology · 2026
    Article
  4. Review
  5. Article
  6. Protein design and RNA design: Perspectives.Quantitative biology (Beijing, China) · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. RNA Structure and Its Function.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Computational De Novo Design of Group II Introns Yields Highly Active Ribozymes.Chembiochem : a European journal of chemical biology · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Shunsuke SumiDepartment of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
Michiaki HamadaGraduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan. mhamada@waseda.jp.ORCID http://orcid.org/0000-0001-9466-1034
Hirohide SaitoDepartment of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan. saitou.hirohide.8a@kyoto-u.ac.jp.ORCID http://orcid.org/0000-0002-8570-5784
Waseda University · JPKyoto University · JP

Funding

MEXT | Japan Society for the Promotion of Science (JSPS) 20H05626MEXT | JST | Core Research for Evolutional Science and Technology (CREST) 21J15897MEXT | JST | Core Research for Evolutional Science and Technology (CREST) JPMJCR21F1MEXT | JST | Core Research for Evolutional Science and Technology (CREST) JPMJCR23B3
6 · The paper itself

Abstract

RNA engineering has immense potential to drive innovation in biotechnology and medicine. Despite its importance, a versatile platform for the automated design of functional RNA is still lacking. Here, we propose RNA family sequence generator (RfamGen), a deep generative model that designs RNA family sequences in a data-efficient manner by explicitly incorporating alignment and consensus secondary structure information. RfamGen can generate novel and functional RNA family sequences by sampling points from a semantically rich and continuous representation. We have experimentally demonstrated the versatility of RfamGen using diverse RNA families. Furthermore, we confirmed the high success rate of RfamGen in designing functional ribozymes through a quantitative massively parallel assay. Notably, RfamGen successfully generates artificial sequences with higher activity than natural sequences. Overall, RfamGen significantly improves our ability to design functional RNA and opens up new potential for generative RNA engineering in synthetic biology.

Indexed as

RNA, CatalyticBiotechnologyHumansRNASynthetic BiologyRNARNA, Catalytic

Identifiers

PMID38238559
OpenAlexW4390975839

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.